Management's conference call to discuss results planned for 8:30 a.m. EDT on October 31
Owens & Minor, Inc. OMI, a global healthcare solutions company, plans to release financial results for the third quarter of 2018 on Wednesday, October 31, 2018, before trading begins on the New York Stock Exchange.
Later that same morning, Owens & Minor's executives will host a conference call at 8:30 a.m. EDT to discuss the results. Participants may access the call at 866-393-1604. The international dial-in number is 224-357-2191. A replay of the call will be available for one week by dialing 855-859-2056. The access code for the conference call, international dial-in and replay is #7399333. A webcast of the event and a corresponding slide presentation will be available on www.owens-minor.com under the Investor Relations section.
About Owens & Minor
Owens &
Minor, Inc. OMI is a global healthcare solutions company with
integrated technologies, products, and services aligned to deliver
significant and sustained value for healthcare providers and
manufacturers across the continuum of care. With 17,000 dedicated
teammates serving healthcare industry customers in 90 countries, Owens &
Minor helps to reduce total costs across the supply chain by optimizing
episode and point-of-care performance, freeing up capital and clinical
resources, and managing contracts to optimize financial performance. A
FORTUNE 500 company, Owens & Minor has annualized revenues of
approximately $10 billion, including contributions from Halyard Health
S&IP. Founded in 1882, Owens & Minor has operated continuously from its
Richmond, Virginia, headquarters. Today, the company now has
distribution, production, customer service and sales facilities located
across Asia, Europe, Latin America, and the U.S. For more information
about Owens & Minor, visit owens-minor.com,
follow @Owens_Minor
on Twitter, and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181026005372/en/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.